Tiffany Traina, MD
Enriched profileBreast Medical Oncologist, Memorial Sloan Kettering Cancer Center; Vice Chair of Outpatient Operations, Department of Medicine; Section Head, Triple Negative Breast Cancer Clinical Research Program · Memorial Sloan Kettering Cancer Center
Tiffany Traina is Breast Medical Oncologist, Memorial Sloan Kettering Cancer Center; Vice Chair of Outpatient Operations, Department of Medicine; Section Head, Triple Negative Breast Cancer Clinical Research Program at Memorial Sloan Kettering Cancer Center. OpenAlex indexes 326 publications with 13,196 citations (h-index 43); ClinicalTrials.gov lists 9 registered studies with this person as an investigator.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
Tiffany Traina, MD, is Breast Medical Oncologist, Memorial Sloan Kettering Cancer Center. The public record shows 326 publications with 13,196 citations (h-index 43), centered on Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, Prostate Cancer Treatment and Research. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 19 companies.
- Top research focus: Breast Cancer Treatment Studies
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 19 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 10 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 103.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
- Feasibility Study of Adjuvant Enzalutamide for the Treatment of Early Stage AR (+) Triple Negative Breast Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Industry payments
Updated 16 Oct 2026
19 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20257 payments$18,190openpaymentsdata.cms.gov ↗
- BioNTech SEProgram year20253 payments$13,500openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202514 payments$13,368openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Aromatase Inhibitor75%Anastrozole83%Exemestane17%Part D<11 patientsEstrogen Agonist/Antagonist13%Tamoxifen Citrate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 16 Oct 2026
98 congress contributions (2005–2026) across AACR, ASCO, ASTRO, SABCS per OpenAlex. The most recent:
- Making telehealth delivery of cancer care at home effective and safe: A pragmatic cluster randomized trial.
ASCO Annual Meeting
ASCO2026Co-author - Modernizing injectable cancer care delivery: A telemedicine-supported home injection model for breast cancer care.
ASCO Annual Meeting
ASCO2026Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: a randomized trial
European Heart Journal
2023 - The Impact of PIK3R1 Mutations and Insulin–PI3K–Glycolytic Pathway Regulation in Prostate Cancer
Clinical Cancer Research
2022
Most-cited works
by citation count (OpenAlex)- 01OncoKB: A Precision Oncology Knowledge BaseArticle2,588 citations2017
- 02Sacituzumab Govitecan in Metastatic Triple-Negative Breast CancerArticle1,683 citations2021
- 03The Genomic Landscape of Endocrine-Resistant Advanced Breast CancersArticle996 citations2018
- 04
- 05Enzalutamide for the Treatment of Androgen Receptor–Expressing Triple-Negative Breast CancerArticle530 citations2018
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/tiffany-traina-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
ascopost.com/videos/42nd-annual-chemotherapy-foundation-symposium/tiffany-traina-on-advances-in-the-treatment-of-hr-positive-breast-cancer
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Other
mskcc.org/cancer-care/doctors/tiffany-traina
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Other
mskcc.org/videos/meet-tiffany-traina-breast-medical-oncologist-at-msk
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Editorial & leadership roles
journal and society appointments- Editorial Board Member
European Journal of Clinical & Medical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Member
New York Metropolitan Breast Cancer Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Panel Member
Translational Breast Cancer Research Consortium Triple Negative Breast Cancer Working Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Scientific Program Committee Member
American Society of Clinical Oncology - Triple-Negative Breast Cancer/Cytotoxics/Local Therapy track
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Secondary affiliations
appointments beyond the home institution- Associate Professor of Medicine
Weill Cornell Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
Mark Kris, MD
Memorial Sloan Kettering Cancer Center
Gabriel Hortobagyi, MD
The University of Texas MD Anderson Cancer Center
Eric Winer, MD
Yale School of Medicine
Hope Rugo, MD
City of Hope
Dennis Slamon, MD
University of California, Los Angeles